“[Cost-Effectiveness Analysis of Delayed-Release Dimethyl-Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy]”. 2016. Farmeconomia. Health Economics and Therapeutic Pathways 17 (2): 67-80. https://doi.org/10.7175/fe.v17i2.1251.